Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis
Hiroshi Mayahara, Jun Itami(National Cancer Centre Japan), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Takuji Okusaka(National Cancer Centre Japan), Shunsuke Kondo(University of Hawaiʻi at Mānoa), Naoya Murakami(Tokushima University Hospital), Yoshinori Ito(National Cancer Center Hospital East), Madoka Morota(Japanese Foundation For Cancer Research), Hideki Ueno, Chigusa Morizane(Tokyo National Hospital)
Cited by 12
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749